Lloyd Laboratories Inc., a firm eyeing to start its production of Molnupiravir this month, is also aiming to apply for an emergency use authorization (EUA) by February for a Covid-19 vaccine that is currently under clinical trials. Antonio Ligsay, medical consultant of the company, told the reporters on Thursday that…